Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

Target action dates for drugs sponsored by Sanofi, Boehringer Ingelheim and Disc Medicine have also been pushed back despite ...

When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those ...

CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...

Kanagawa University of Human Services-led researchers found short-term BMI reductions after an eight-to-12-week ...

CenterWell Pharmacy announced that it will dispense Eli Lilly's obesity drugs within employer weight management programs. | ...

Eli Lilly working Humana to distribute obesity medications through employer-focused programs via CenterWell Pharmacy.

The research, published in the British Medical Journal on Thursday, adds to a growing body of evidence that suggests ...

A low-carbohydrate diet combined with resistance training achieves notable weight loss even in individuals with a high ...

Obesity is a growing national health crisis, with nearly 40% of U.S. adults affected and about 10% having a severe form of ...

Weight management medications show limited long-term effects, with rapid weight regain post-treatment, emphasizing the need ...

As California ends Medicaid coverage for GLP-1 weight loss drugs like Wegovy and Zepbound, experts say the state's advice to ...